Oppilan Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $14M

Oppilan Pharma General Information

Description

Developer of novel small molecule therapeutics designed to treat autoimmune diseases. The company's molecule is a potent and selective modulator of sphingosine, enabling patients and the medical community to optimally combat inflammatory bowel diseases.

Contact Information

Website
www.oppilan.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Saint John's Innovation Centre
  • Cowley Road
  • Cambridge CB4 0WS
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Ventyx Biosciences
Vertical(s)
Life Sciences
Corporate Office
  • Saint John's Innovation Centre
  • Cowley Road
  • Cambridge CB4 0WS
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oppilan Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Feb-2021 $14M Completed Clinical Trials - General
1. Early Stage VC 30-Dec-2016 Completed Clinical Trials - General
To view Oppilan Pharma’s complete valuation and funding history, request access »

Oppilan Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Oppilan Pharma’s complete cap table history, request access »

Oppilan Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oppilan Pharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Science Ventures Venture Capital Minority
Third Point Ventures Corporate Venture Capital Minority
To view Oppilan Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Oppilan Pharma FAQs

  • When was Oppilan Pharma founded?

    Oppilan Pharma was founded in 2015.

  • Where is Oppilan Pharma headquartered?

    Oppilan Pharma is headquartered in Cambridge, United Kingdom.

  • What is the size of Oppilan Pharma?

    Oppilan Pharma has 2 total employees.

  • What industry is Oppilan Pharma in?

    Oppilan Pharma’s primary industry is Drug Discovery.

  • Is Oppilan Pharma a private or public company?

    Oppilan Pharma is a Private company.

  • What is the current valuation of Oppilan Pharma?

    The current valuation of Oppilan Pharma is .

  • What is Oppilan Pharma’s current revenue?

    The current revenue for Oppilan Pharma is .

  • How much funding has Oppilan Pharma raised over time?

    Oppilan Pharma has raised $4.68M.

  • Who are Oppilan Pharma’s investors?

    New Science Ventures and Third Point Ventures have invested in Oppilan Pharma.

  • When was Oppilan Pharma acquired?

    Oppilan Pharma was acquired on 01-Feb-2021.

  • Who acquired Oppilan Pharma?

    Oppilan Pharma was acquired by Ventyx Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »